Kimmie K McLaurin

Summary

Affiliation: MedImmune Vaccines
Country: USA

Publications

  1. ncbi request reprint Persistence of morbidity and cost differences between late-preterm and term infants during the first year of life
    Kimmie K McLaurin
    Health Outcomes and Pharmacoeconomics, MedImmune, One MedImmune Way, Gaithersburg, MD 20878, USA
    Pediatrics 123:653-9. 2009
  2. pmc A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma
    Chad K Oh
    MedImmune, One MedImmune Way, Gaithersburg, MD, USA
    Respir Res 14:93. 2013

Collaborators

Detail Information

Publications2

  1. ncbi request reprint Persistence of morbidity and cost differences between late-preterm and term infants during the first year of life
    Kimmie K McLaurin
    Health Outcomes and Pharmacoeconomics, MedImmune, One MedImmune Way, Gaithersburg, MD 20878, USA
    Pediatrics 123:653-9. 2009
    ..Late-preterm infants are known to have greater morbidity and costs compared with term infants during the neonatal period, but less is known about whether these differences continue beyond this period...
  2. pmc A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma
    Chad K Oh
    MedImmune, One MedImmune Way, Gaithersburg, MD, USA
    Respir Res 14:93. 2013
    ..The aim of this study was therefore to evaluate the effects of MEDI-528, an anti-interleukin-9 monoclonal antibody, in adults with confirmed uncontrolled moderate-to-severe asthma...